Janney Montgomery Scott
INSY

Janney Montgomery Scott’s Insys Therapeutics, Inc. INSY Stock Holding History

Janney Montgomery Scott’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,625
Closed -$147K – 2124
2018
Q3 		$147K Buy
14,625
+2,200
+18% +$17.5K ﹤0.01% 1960
2018
Q2 		$90K Sell
12,425
-26,859
-68% -$187K ﹤0.01% 1952
2018
Q1 		$237K Buy
+39,284
New +$324K ﹤0.01% 1729
2017
Q4 		– Sell
-15,150
Closed -$135K – 1999
2017
Q3 		$135K Buy
+15,150
New +$156K ﹤0.01% 1767
2017
Q2 		– Sell
-17,900
Closed -$188K – 1842
2017
Q1 		$188K Buy
+17,900
New +$191K ﹤0.01% 1634

Other funds holding INSY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Janney Montgomery Scott's INSY Position: Q4 2018 in Review

Janney Montgomery Scott sold out of Insys Therapeutics, Inc. (INSY) in Q4 2018, closing a stake of 14,625 shares — an estimated $147K sold.

Janney Montgomery Scott first reported a position in INSY in Q1 2017 and held it in 5 quarters. The position peaked at $237K in Q1 2018. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

  • Janney Montgomery Scott reported no remaining Insys Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 14,625 Insys Therapeutics, Inc. shares in Q4 2018, an estimated $147K.
  • Janney Montgomery Scott first reported a position in Insys Therapeutics, Inc. in Q1 2017 and held it in 5 quarters.
  • Janney Montgomery Scott's Insys Therapeutics, Inc. position peaked at $237K in Q1 2018.
  • 113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on Janney Montgomery Scott's 13F filing for Q4 2018, filed 1 Feb 2019.